法国初创公司AZmed近日宣布，其开发的人工智能医学成像软件Rayvolve已完成1500万欧元的A轮融资。本轮融资由Maison Worms、Techstars和Tempact Ventures等投资者共同参与。
AZmed表示，Rayvolve是一款具有创新性的诊断辅助工具，利用人工智能技术对放射照相结果进行深度分析。通过识别标准放射照相中的各种异常情况，如病变、骨折等，Rayvolve旨在为放射科医生和急诊医生提供更为精准的诊断结果，从而节省他们的时间，提高工作效率。同时，该软件还有助于降低诊断错误的风险，为患者提供更高质量的治疗方案。
据悉，Rayvolve软件已在一系列临床研究中展现出良好的性能，未来有望广泛应用于医疗领域。此次融资的成功将为AZmed带来更多发展机遇，推动公司进一步拓展市场，加速产品的商业化进程。
投资方表示，人工智能在医疗领域的应用前景广阔，AZmed团队凭借其在医学成像领域的专业知识和丰富经验，有望将Rayvolve打造成为行业领导者。此外，投资者还表示，支持AZmed的发展，也是对创新医疗技术的一种投资，有助于提高医疗服务的质量和效率，造福更多患者。
AZmed表示，融资成功后，公司将继续加大研发投入，进一步优化Rayvolve软件的功能和性能，并寻求与其他医疗机构、药企和科研机构的合作，共同推动人工智能医学成像技术的发展。
英语如下：
**News Title: AI Medical Imaging Startup AZmed Raises €15 Million**
Keywords: AZmed Funding, AI Medical Imaging, Rayvolve Software
**News Content:**
French startup AZmed recently announced that its artificial intelligence-based medical imaging software, Rayvolve, has completed a €15 million Series A round of financing. This round of funding was jointly participated by investors including Maison Worms, Techstars, and Tempact Ventures.
AZmed stated that Rayvolve is an innovative diagnostic assistive tool that leverages artificial intelligence technology for in-depth analysis of radiographic results. By identifying various abnormalities in standard radiography, such as lesions and fractures, Rayvolve aims to provide more precise diagnostic results for radiologists and emergency doctors, thus saving their time and improving work efficiency. Additionally, the software helps reduce the risk of diagnostic errors and enables patients to receive higher-quality treatment plans.
It is understood that Rayvolve software has shown good performance in a series of clinical studies and is expected to be widely used in the medical field in the future. The success of this round of financing will bring more development opportunities to AZmed, promote further market expansion, and accelerate the commercialization of products.
The investors mentioned that the application prospects of artificial intelligence in the medical field are vast, and the AZmed team, with its professional knowledge and experience in medical imaging, is expected to make Rayvolve a leader in the industry. Moreover, they stated that supporting the development of AZmed is also an investment in innovative medical technology, which helps improve the quality and efficiency of medical services and benefits more patients.
AZmed said that after the successful financing, the company will continue to increase its research and development investment, further optimize the functionality and performance of the Rayvolve software, and seek cooperation with other medical institutions, pharmaceutical companies, and scientific research institutions to jointly promote the development of artificial intelligence medical imaging technology.
【来源】https://tech.eu/2024/02/20/french-medtech-azmed-raises-eur15m/
Views: 2